Barbital

NERVOUS SYSTEM

Key facts

Barbital is a drug catalogued in DrugCentral. Recorded indications include Insomnia.

• Indications: Insomnia.
• ATC code: N05CA04 (Barbiturates, plain).
• Molecular formula: C8H12N2O3; molecular weight 184.19 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Insomnia

ATC classification

ATC code	Therapeutic hierarchy
N05CA04	NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Barbiturates, plain

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Barbital is on its molecule page.

• Molecular formula: C₈H₁₂N₂O₃
• Molecular weight: 184.19 g/mol
• CAS number: 57-44-3
• InChIKey: FTOAOBMCPZCFFF-UHFFFAOYSA-N
• PubChem CID: 2294

CCC1(CC)C(=O)NC(=O)NC1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Barbital used for?

DrugCentral lists the following indications for Barbital: Insomnia.

What is the chemical formula of Barbital?

Barbital has the molecular formula C8H12N2O3 and a molecular weight of 184.19 g/mol.

Sources

• DrugCentral drug card 289 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2105904 — compound record and bioactivity
• PubChem CID 2294 — chemical identifiers
• DrugBank DB01483 — drug record
• FDA UNII 5WZ53ENE2P — substance identity

How this page is built: methodology · editorial policy & corrections.